Publication
Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes
dc.contributor.author | Coelho, João | |
dc.contributor.author | Malheiro, Luisa | |
dc.contributor.author | Melo Beirão, João | |
dc.contributor.author | Meireles, Angelina | |
dc.contributor.author | Pessoa, Bernardete | |
dc.date.accessioned | 2020-05-06T22:43:34Z | |
dc.date.available | 2020-05-06T22:43:34Z | |
dc.date.issued | 2019 | |
dc.description.abstract | Purpose: The aim of this study was to evaluate the long-term real-world effectiveness of FAc and DEX implants in vitrectomized DME eyes in a real-world setting. Methods: This was a non-interventional, retrospective, comparative study of 46 vitrectomized eyes in 33 patients with persistent or recurrent DME quantified best-corrected visual acuity (BCVA), central foveal thickness (CFT) and intraocular pressure (IOP) over up to 37 months. Results: Both FAc and DEX treatment led to statistically and clinically significant improvements in BCVA and CFT. FAc >10-letter improvement on the Early Treatment Diabetic Retinopathy Study [ETDRS] chart over months 3-24 and a sustained ~200 µm CFT reduction over months 1-24; DEX: >5-letter improvement on the ETDRS chart at months 1 and 3 and >100 µm CFT reduction at month 1. FAc demonstrated sustained, stable and predictable effects on BCVA and CFT over 24 months and also improved BCVA and decreased CFT in a cohort of DME eyes that was refractory to DEX over 6 months. Conclusion: This real-world study demonstrates long-term effectiveness of FAc in vitrectomized DME eyes and sustained effectiveness in DME eyes that did not respond to DEX therapy. | pt_PT |
dc.description.sponsorship | Writing support was provided by Hayward Medical Communications and funded by Alimera Sciences Ltd. This paper was funded by Alimera Sciences Ltd. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Coelho J, Malheiro L, Melo Beirão J, Meireles A, Pessoa B. Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes. Clin Ophthalmol. 2019;13:1751‐1759. Published 2019 Sep 9. doi:10.2147/OPTH.S201611 | pt_PT |
dc.identifier.doi | 10.2147/OPTH.S201611 | pt_PT |
dc.identifier.issn | 1177-5467 | |
dc.identifier.issn | 1177-5483 | |
dc.identifier.uri | http://hdl.handle.net/10400.16/2369 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Dove Medical Press | pt_PT |
dc.relation.publisherversion | https://www.dovepress.com/real-world-retrospective-comparison-of-019-mg-fluocinolone-acetonide-a-peer-reviewed-article-OPTH | pt_PT |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | pt_PT |
dc.subject | dexamethasone implant | pt_PT |
dc.subject | diabetic macular edema | pt_PT |
dc.subject | fluocinolone acetonide | pt_PT |
dc.subject | intravitreal implants | pt_PT |
dc.subject | real-world | pt_PT |
dc.subject | vitrectomy | pt_PT |
dc.title | Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.conferencePlace | New Zealand | pt_PT |
oaire.citation.endPage | 1759 | pt_PT |
oaire.citation.startPage | 1751 | pt_PT |
oaire.citation.title | Clinical ophthalmology (Auckland, N.Z.) | pt_PT |
oaire.citation.volume | 13 | pt_PT |
person.familyName | Coelho | |
person.familyName | Malheiro | |
person.familyName | Meireles | |
person.familyName | Pessoa | |
person.givenName | João | |
person.givenName | Luisa | |
person.givenName | Angelina | |
person.givenName | Bernardete | |
person.identifier.ciencia-id | 0E1B-7EB2-B90F | |
person.identifier.orcid | 0000-0003-2261-5682 | |
person.identifier.orcid | 0000-0001-9937-6806 | |
person.identifier.orcid | 0000-0001-9148-2786 | |
person.identifier.orcid | 0000-0002-5673-1561 | |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | 9d2244b9-b054-46ab-8d35-d0a369849715 | |
relation.isAuthorOfPublication | 786469ad-6b28-478e-b7b5-5e4cde542164 | |
relation.isAuthorOfPublication | 8832627a-5103-43bb-a479-6556c8b18d44 | |
relation.isAuthorOfPublication | fa0e3b13-5da3-4f74-a184-22358fc19d38 | |
relation.isAuthorOfPublication.latestForDiscovery | 9d2244b9-b054-46ab-8d35-d0a369849715 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Real-world retrospective comparison.pdf
- Size:
- 1.53 MB
- Format:
- Adobe Portable Document Format